The Study Patients: Late stage ARDS according to American European Consensus Conference criteria still requiring mechanical ventilation for 7-28 days after onset of ARDS. Control group (N = 91; 91 analysed): No specified ventilatory strategy (probably not controlled) until 1999 then standard ARDSnet ventilation strategy after 1999 and weaned according to a standardised weaning protocol.
Experimental group (N = 89; 89 analysed): No specified ventilatory strategy (probably not controlled) until 1999 then standard ARDSnet ventilation strategy after 1999 and weaned according to a standard weaning protocol plus the addition of corticosteroids. Methylprednisolone 2mg/kg as one off dose followed by 0.5mg/kg six hourly for 14 days, 0.5mg/kg twelve hourly for 7 days then tapered to off over 4 days if still ventilated or over 2 days if not ventilated or patient had developed fungal infection or septic shock. 
Corticosteroids in Late ARDS

Are conclusions valid in light of the results?
They conclude that the results do not support the routine use of methlyprednisolone in prolonged ARDS. This is a reasonable conclusion. They also conclude that starting methylprednisolone more than two weeks after onset of ARDS may increase mortality. This may lack validity due to very small event numbers. 
